Protagonist Therapeutics
PTGX
#2239
Rank
NZ$15.11 B
Marketcap
NZ$231.60
Share price
2.00%
Change (1 day)
55.31%
Change (1 year)

Market capitalization of Protagonist Therapeutics (PTGX)

Market cap: NZ$15.11 Billion

As of November 2026 Protagonist Therapeutics has a market cap of NZ$15.11 Billion. This makes Protagonist Therapeutics the world's 2239th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protagonist Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$15.11 B57.74%
2025NZ$9.58 B132.77%
2024NZ$4.11 B96.87%
2023NZ$2.09 B147.37%
2022NZ$0.84 B-64.62%
2021NZ$2.38 B98.82%
2020NZ$1.20 B321.86%
2019NZ$0.28 B22.47%
2018NZ$0.23 B-62.19%
2017NZ$0.61 B15.96%
2016NZ$0.53 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Protagonist Therapeutics was reported to be:

NZ$15.11 Billion
by Nasdaq info icon info icon
NZ$15.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.44 B-90.42%๐Ÿ‡บ๐Ÿ‡ธ USA